4-Chloromethcathinone
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | 1225843-86-6 |
PubChem (CID) | 82100418 |
ChemSpider | 25630416 |
Chemical and physical data | |
Formula | C10H12ClNO |
Molar mass | 197.66 g/mol |
3D model (Jmol) | Interactive image |
| |
|
4-Chloromethcathinone (also known as 4-CMC and Clephedrone) is a stimulant drug of the cathinone class that has been sold online as a designer drug.[1][2][3]
Legality
Clephedrone is an Anlage I controlled drug in Germany.
Sweden's public health agency suggested classifying 4-Chloromethcathinone (klefedron) as illegal narcotic on June 1, 2015.[4]
As of October 2015 4-CMC is a controlled substance in China.[5]
4-CMC is considered a Schedule 1 substance in Virginia.[6]
See also
- 4-Bromomethcathinone
- 4-Chloroamphetamine
- 4-Ethylmethcathinone
- 4-Methylmethcathinone
- Substituted cathinone
References
- ↑ "4-Chloromethcathinone". Cayman Chemical. Retrieved 5 September 2015.
- ↑ Magdalena Taschwer; Jennifer A. Weiß; Olaf Kunert; Martin G. Schmid (November 2014). "Analysis and characterization of the novel psychoactive drug 4-chloromethcathinone (clephedrone)". Forensic Science International. 244: 56–59. doi:10.1016/j.forsciint.2014.09.007. PMID 25280452.
- ↑ Janez Klavž; Maksimiljan Gorenjak; Martin Marinšek (August 2016). "Suicide attempt with a mix of synthetic cannabinoids and synthetic cathinones: Case report of non-fatal intoxication with AB-CHMINACA, AB-FUBINACA, alpha-PHP, alpha-PVP and 4-CMC". Forensic Science International. 265: 121–124. doi:10.1016/j.forsciint.2016.01.018.
- ↑ "23 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 1 June 2015. Retrieved 5 September 2015.
- ↑ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
- ↑ "18VAC110-20-322. Placement of Chemicals in Schedule I.". Commonwealth of Virginia. 2 December 2015. Retrieved 11 March 2016.
This article is issued from Wikipedia - version of the 5/17/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.